OFF-LABEL COMPARATORS IN HEALTH TECHNOLOGY ASSESSMENT DECISION MAKING IN PORTUGAL

被引:0
|
作者
Ferreira, A. S. [1 ]
Parreia, Felix J. [1 ]
Pereira, P. [1 ]
机构
[1] Exigo Consultores, Lisbon, Portugal
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
HTA148
引用
收藏
页码:S382 / S382
页数:1
相关论文
共 50 条
  • [1] AN UPDATE ON HOW NICE MANAGE OFF-LABEL COMPARATORS
    Kusel, J.
    Steeves, S.
    Maruszczak, M.
    Pettit, L. J.
    Taylor, D.
    VALUE IN HEALTH, 2014, 17 (03) : A14 - A14
  • [2] Should Off-Label Drugs Be Included as Comparators in Pharmacoeconomic Studies?
    Surrey M. Walton
    Glen T. Schumock
    PharmacoEconomics, 2014, 32 : 1035 - 1037
  • [3] Should Off-Label Drugs Be Included as Comparators in Pharmacoeconomic Studies?
    Walton, Surrey M.
    Schumock, Glen T.
    PHARMACOECONOMICS, 2014, 32 (11) : 1035 - 1037
  • [4] THE USE OF OFF-LABEL COMPARATORS IN NICE APPRAISALS - AN INDIRECT ENDORSEMENT?
    Kusel, J.
    Wong, G. K.
    VALUE IN HEALTH, 2012, 15 (07) : A278 - A278
  • [5] IV Lidocaine for Status Migraine: Making an "Off-Label" Treatment Decision
    Tasker, Robert C.
    PEDIATRIC CRITICAL CARE MEDICINE, 2018, 19 (08) : 786 - 787
  • [6] AN ASSESSMENT OF FACTORS IMPACTING THE LAUNCH OF INNOVATIVE DRUGS IN THERAPY AREAS WITH POTENTIAL OFF-LABEL COMPARATORS
    Borga, P.
    VALUE IN HEALTH, 2020, 23 : S609 - S609
  • [7] Assessment off-label prescribing in dermatology
    Picard, D
    Carvalho, P
    Bonnavia, C
    Louin, L
    Josset, V
    Lauret, P
    Joly, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2003, 130 (05): : 507 - 510
  • [8] Boxed Warnings and Off-Label Use of Allergy Medications: Risks, Benefits, and Shared Decision Making
    Greiwe, Justin
    Honsinger, Richard
    Hvisdas, Christopher
    Chu, Derek K.
    Lang, David M.
    Nicklas, Richard
    Apter, Andrea J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (12): : 3057 - 3063
  • [9] Informed Consent and Shared Decision-Making: A Requirement to Disclose to Patients Off-Label Prescriptions
    Wilkes, Michael
    Johns, Margaret
    PLOS MEDICINE, 2008, 5 (11) : 1553 - 1556
  • [10] The changing landscape of off-label prescription drug promotion Opportunities to improve decision-making
    Sarkees, Matthew E.
    Fitzgerald, M. Paula
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2016, 10 (02) : 148 - 160